BACKGROUND: It is unclear whether the normative sequence of drug use initiation, beginning with tobacco and alcohol, progressing to cannabis and then other illicit drugs, is due to causal effects of specific earlier drug use promoting progression, or to influences of other variables such as drug availability and attitudes. One way to investigate this is to see whether risk of later drug use in the sequence, conditional on use of drugs earlier in the sequence, changes according to time-space variation in use prevalence. We compared patterns and order of initiation of alcohol, tobacco, cannabis, and other illicit drug use across 17 countries with a wide range of drug use prevalence. METHOD: Analyses used data from World Health Organization (WHO) World Mental Health (WMH) Surveys, a series of parallel community epidemiological surveys using the same instruments and field procedures carried out in 17 countries throughout the world. RESULTS: Initiation of "gateway" substances (i.e. alcohol, tobacco and cannabis) was differentially associated with subsequent onset of other illicit drug use based on background prevalence of gateway substance use. Cross-country differences in substance use prevalence also corresponded to differences in the likelihood of individuals reporting a non-normative sequence of substance initiation. CONCLUSION: These results suggest the "gateway" pattern at least partially reflects unmeasured common causes rather than causal effects of specific drugs on subsequent use of others. This implies that successful efforts to prevent use of specific "gateway" drugs may not in themselves lead to major reductions in the use of later drugs. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.
BACKGROUND: It is unclear whether the normative sequence of drug use initiation, beginning with tobacco and alcohol, progressing to cannabis and then other illicit drugs, is due to causal effects of specific earlier drug use promoting progression, or to influences of other variables such as drug availability and attitudes. One way to investigate this is to see whether risk of later drug use in the sequence, conditional on use of drugs earlier in the sequence, changes according to time-space variation in use prevalence. We compared patterns and order of initiation of alcohol, tobacco, cannabis, and other illicit drug use across 17 countries with a wide range of drug use prevalence. METHOD: Analyses used data from World Health Organization (WHO) World Mental Health (WMH) Surveys, a series of parallel community epidemiological surveys using the same instruments and field procedures carried out in 17 countries throughout the world. RESULTS: Initiation of "gateway" substances (i.e. alcohol, tobacco and cannabis) was differentially associated with subsequent onset of other illicit drug use based on background prevalence of gateway substance use. Cross-country differences in substance use prevalence also corresponded to differences in the likelihood of individuals reporting a non-normative sequence of substance initiation. CONCLUSION: These results suggest the "gateway" pattern at least partially reflects unmeasured common causes rather than causal effects of specific drugs on subsequent use of others. This implies that successful efforts to prevent use of specific "gateway" drugs may not in themselves lead to major reductions in the use of later drugs. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.
Entities:
Keywords:
WHO World Mental Health Surveys; alcohol; gateway; illicit drugs; tobacco
Authors: Ronald C Kessler; Jamie Abelson; Olga Demler; Javier I Escobar; Miriam Gibbon; Margaret E Guyer; Mary J Howes; Robert Jin; William A Vega; Ellen E Walters; Philip Wang; Alan Zaslavsky; Hui Zheng Journal: Int J Methods Psychiatr Res Date: 2004 Impact factor: 4.035
Authors: J Alonso; M Ferrer; B Romera; G Vilagut; M Angermeyer; S Bernert; T S Brugha; N Taub; Z McColgen; G de Girolamo; G Polidori; F Mazzi; R De Graaf; W A M Vollebergh; M A Buist-Bowman; K Demyttenaere; I Gasquet; J M Haro; C Palacín; J Autonell; S J Katz; R C Kessler; V Kovess; J P Lépine; S Arbabzadeh-Bouchez; J Ormel; R Bruffaerts Journal: Int J Methods Psychiatr Res Date: 2002 Impact factor: 4.035
Authors: L Degenhardt; W T Chiu; K Conway; L Dierker; M Glantz; A Kalaydjian; K Merikangas; N Sampson; J Swendsen; R C Kessler Journal: Psychol Med Date: 2008-05-09 Impact factor: 7.723
Authors: João Maurício Castaldelli-Maia; Sérgio Nicastri; Lúcio Garcia de Oliveira; Arthur Guerra de Andrade; Silvia S Martins Journal: Exp Clin Psychopharmacol Date: 2014-08-25 Impact factor: 3.157
Authors: Erin E Morgan; Steven P Woods; Amelia J Poquette; Ofilio Vigil; Robert K Heaton; Igor Grant Journal: Aust N Z J Psychiatry Date: 2012-02 Impact factor: 5.744
Authors: João Mauricio Castaldelli-Maia; Silvia S Martins; Lúcio Garcia de Oliveira; Margriet van Laar; Arthur Guerra de Andrade; Sergio Nicastri Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2013-08-06 Impact factor: 4.328